EGF816 (Nazartinib)
Important Notice: For research use only. We do not sell to patients.
Other Forms of EGF816 (Nazartinib)
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | EGF816 is a novel covalent inhibitor of mutant-selective EGFR; overcomes T790M-mediated resistance in NSCLC. | ||
---|---|---|---|
Targets |
|
Catalog Num | A14416 |
---|---|
Formula | C26H31ClN6O2 |
Molecular Weight | 495.02 |
CAS Number | 1508250-71-2 |
SMILES | CC1=NC=CC(=C1)C(=O)NC2=NC3=C(N2C4CCCCN(C4)C(=O)C=CCN(C)C)C(=CC=C3)Cl |
Synonyms | EGF-816, EGF 816, Nazartinib |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 92 mg/mL (185.85 mM) | |
Water | Insoluble | ||
Ethanol | 92 mg/mL (185.85 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 20.2 mL | 101.01 mL | 202.01 mL |
0.5 mM | 4.04 mL | 20.2 mL | 40.4 mL |
1 mM | 2.02 mL | 10.1 mL | 20.2 mL |
5 mM | 0.4 mL | 2.02 mL | 4.04 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2